Coronavirus information for Feinberg.

Skip to main content

News and Announcements

Read the latest news from Northwestern University Feinberg School of Medicine’s basic science academic departments. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.

Biochemistry and Molecular Genetics

Cell and Developmental Biology

  • 09.09.2021

    A novel combination treatment may increase the ability of monoclonal antibodies to control viral infection in patients diagnosed with HIV, according to a Northwestern Medicine study.

  • 08.20.2021

    An international collaboration for which Luisa Iruela-Arispe, PhD, chair of Cell and Developmental Biology, serves as North American coordinator, has received a five-year, $7 million Transatlantic Networks of Excellence Program award from the Leducq Foundation.

  • 08.20.2021

    Northwestern Medicine investigators have discovered that a subset of proteins in mitochondria of brain and heart cells are long-lived, supporting the long-term stability of mitochondrial complex architecture.


  • 09.21.2021
    A Q&A with Hank Seifert, PhD, the John Edward Porter Professor of Biomedical Research and professor of Microbiology-Immunology.
  • 08.18.2021

    In a new Northwestern Medicine study in mice, researchers took one of the current vaccines, which is based on the novel coronavirus’ infamous spike protein, and added a different antigen, the nucleocapsid protein, to form a new, potentially improved version of the COVID vaccine. The nucleocapsid protein, which is an internal RNA-binding protein, may help kick the immune system into high gear much more quickly than the spike protein is capable of since it is among the most rapidly and highly expressed proteins in coronaviruses.

    “At this point, we’re just trying to figure out ‘What should the 2.0 vaccines be?’” said senior and corresponding study author Pablo Penaloza-MacMaster, PhD, assistant professor of microbiology-immunology at Northwestern University Feinberg School of Medicine. “It seems like adding nucleocapsid to the vaccine renders it more protective, relative to having only the spike.”

  • 08.10.2021

    Inefficient cardiac repair after heart attacks is partially driven by a maladapted response to a low oxygen environment by immune cells, according to a study published in the Journal of Experimental Medicine.